{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:05:39Z","timestamp":1788570339958,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Robert Koch Institute through funds from the Federal Ministry of Health","award":["1369\u2013341"],"award-info":[{"award-number":["1369\u2013341"]}]},{"name":"Spanish Ministry of Health","award":["CP16\/00041"],"award-info":[{"award-number":["CP16\/00041"]}]},{"DOI":"10.13039\/501100008530","name":"Fondo Europeo de Desarrollo Regional","doi-asserted-by":"crossref","award":["POCTEFA 2014-2020"],"award-info":[{"award-number":["POCTEFA 2014-2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12035-018-1251-1","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T07:54:37Z","timestamp":1532937277000},"page":"2811-2821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases"],"prefix":"10.1007","volume":"56","author":[{"given":"Anna","family":"Villar-Piqu\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5502-681X","authenticated-orcid":false,"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Karch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Calero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Stehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Sarros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ladogana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Poleggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidre","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Mitrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"\u017d\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Pocchiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Baldeiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Calero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Geschwind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"S\u00e1nchez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc","family":"Llorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"1251_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev.pathmechdis.3.121806.154326","volume":"3","author":"A Aguzzi","year":"2008","unstructured":"Aguzzi A, Sigurdson C, Heikenwaelder M (2008) Molecular mechanisms of prion pathogenesis. Annu Rev Pathol Mech Dis 3:11\u201340","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"1251_CR2","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/j.1471-4159.2006.03909.x","volume":"97","author":"A Aguzzi","year":"2006","unstructured":"Aguzzi A (2006) Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis. J Neurochem 97:1726\u20131739","journal-title":"J Neurochem"},{"key":"1251_CR3","doi-asserted-by":"crossref","unstructured":"Chen C, Dong X-P (2016) Epidemiological characteristics of human prion diseases. Infect Dis Poverty [Internet] 5:47. Available from: \n                    http:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-016-0143-8","DOI":"10.1186\/s40249-016-0143-8"},{"key":"1251_CR4","unstructured":"Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol [Internet] 39:767\u201378. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8651649"},{"key":"1251_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224\u2013233","journal-title":"Ann Neurol"},{"issue":"4","key":"1251_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/GIM.0b013e3181cd7374","volume":"12","author":"James A Mastrianni","year":"2009","unstructured":"Mastrianni JA (2010) The genetics of prion diseases. Genet Med 12:187\u201395","journal-title":"Genetics in Medicine"},{"issue":"3","key":"1251_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.gde.2013.02.012","volume":"23","author":"Sarah E Lloyd","year":"2013","unstructured":"Lloyd SE, Mead S, Collinge J (2013) Genetics of prion diseases. Curr Opin Genet Dev 345\u201351","journal-title":"Current Opinion in Genetics & Development"},{"issue":"1","key":"1251_CR8","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2016.5.FOCUS15126","volume":"41","author":"David J. Bonda","year":"2016","unstructured":"Bonda DJ, Manjila S, Mehndiratta P, Khan F, Miller BR, Onwuzulike K et al (2016) Human prion diseases: surgical lessons learned from iatrogenic prion transmission. Neurosurg Focus 41:E10","journal-title":"Neurosurgical Focus"},{"issue":"1","key":"1251_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ana.410430109","volume":"43","author":"Inga Zerr","year":"1998","unstructured":"Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA et al (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 43:32\u201340","journal-title":"Annals of Neurology"},{"key":"1251_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","volume":"225","author":"M Otto","year":"1997","unstructured":"Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J et al (1997) Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 225:210\u2013212","journal-title":"Neurosci Lett"},{"issue":"6","key":"1251_CR11","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jalz.2016.09.013","volume":"13","author":"Franc Llorens","year":"2017","unstructured":"Llorens F, Kruse N, Schmitz M, Gotzmann N, Golanska E, Th\u00fcne K, Zejneli O, Kanata E et al (2017) Evaluation of \u03b1-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases. Alzheimers Dement 13:710\u2013719","journal-title":"Alzheimer's & Dementia"},{"issue":"2","key":"1251_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"Ryuichiro Atarashi","year":"2011","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T et al (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17:175\u2013178","journal-title":"Nature Medicine"},{"key":"1251_CR13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3233\/JAD-2009-1110","volume":"17","author":"F Meyne","year":"2009","unstructured":"Meyne F, Gloeckner SF, Ciesielczyk B, Heinemann U, Krasnianski A, Meissner B, Zerr I (2009) Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J Alzheimers Dis 17:863\u2013873","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1251_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jamaneurol.2014.4068","volume":"72","author":"Aline Dorey","year":"2015","unstructured":"Dorey A, Tholance Y, Vighetto A, Perret-Liaudet A, Lachman I, Krolak-Salmon P, Wagner U, Struyfs H et al (2015) Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease. JAMA Neurol 72:267\u2013275","journal-title":"JAMA Neurology"},{"key":"1251_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-160665","volume":"55","author":"SA Rumeileh","year":"2016","unstructured":"Rumeileh SA, Lattanzio F, Maserati MS, Rizzi R, Capellari S, Parchi P (2016) Diagnostic accuracy of a combined analysis of cerebrospinal fluid t-PrP, t-tau, p-tau, and A\u03b242 in the differential diagnosis of Creutzfeldt-Jakob disease from Alzheimer\u2019s disease with emphasis on atypical disease variants. J Alzheimers Dis 55:1\u201310","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1251_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4161\/pri.26416","volume":"7","author":"Franc Llorens","year":"2013","unstructured":"Llorens F, Ansoleaga B, Garcia-Esparcia P, Zafar S, Grau-Rivera O, L\u00f3pez-Gonz\u00e1lez I, Blanco R et al (2013) PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2. Prion 7:383\u201393","journal-title":"Prion"},{"issue":"11","key":"1251_CR17","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1111\/j.1460-9568.2010.07224.x","volume":"31","author":"Matthias Schmitz","year":"2010","unstructured":"Schmitz M, Schlomm M, Hasan B, Beekes M, Mitrova E, Korth C, Breil A, Carimalo J et al (2010) Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt-Jakob disease. Eur J Neurosci 31:2024\u20132031","journal-title":"European Journal of Neuroscience"},{"key":"1251_CR18","doi-asserted-by":"publisher","first-page":"e36159","DOI":"10.1371\/journal.pone.0036159","volume":"7","author":"M Torres","year":"2012","unstructured":"Torres M, Cartier L, Matamala JM, Hern\u00e1ndez N, Woehlbier U, Hetz C (2012) Altered prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease. PLoS One 7:e36159","journal-title":"PLoS One"},{"issue":"5","key":"1251_CR19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.neurobiolaging.2013.11.010","volume":"35","author":"Matthias Schmitz","year":"2014","unstructured":"Schmitz M, L\u00fcllmann K, Zafar S, Ebert E, Wohlhage M, Oikonomou P, Schlomm M, Mitrova E et al (2014) Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases. Neurobiol Aging 35:1177\u20131188","journal-title":"Neurobiology of Aging"},{"issue":"10","key":"1251_CR20","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I. Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132:2659\u20132668","journal-title":"Brain"},{"key":"1251_CR21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","volume":"124","author":"P Parchi","year":"2012","unstructured":"Parchi P, De Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P et al (2012) Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124:517\u2013529","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1251_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","volume":"118","author":"G\u00e1bor G. Kov\u00e1cs","year":"2005","unstructured":"Kov\u00e1cs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A et al (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118:166\u2013174","journal-title":"Human Genetics"},{"key":"1251_CR23","unstructured":"World Health Organisation (2003) WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease. WHO Man. Surveill. Hum. Transm. spongiform Enceph 105"},{"issue":"3","key":"1251_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s004390051096","volume":"105","author":"O. Windl","year":"1999","unstructured":"Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, Oberdieck C, Bodemer M et al (1999) Molecular genetics of human prion diseases in Germany. Hum Genet 105:244\u2013252","journal-title":"Human Genetics"},{"key":"1251_CR25","doi-asserted-by":"publisher","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, M\u00fcller M (2011). pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77. \n                    https:\/\/doi.org\/10.1186\/1471-2105-12-77","DOI":"10.1186\/1471-2105-12-77"},{"issue":"5","key":"1251_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jalz.2015.10.009","volume":"12","author":"Franc Llorens","year":"2016","unstructured":"Llorens F, Schmitz M, Karch A, Cramm M, Lange P, Gherib K, Varges D, Schmidt C et al (2016) Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia. Alzheimers Dement 12:577\u2013589","journal-title":"Alzheimer's & Dementia"},{"issue":"10","key":"1251_CR27","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1007\/s00415-009-5163-x","volume":"256","author":"Anna Ladogana","year":"2009","unstructured":"Ladogana A, Sanchez-Juan P, Mitrova E, Green A, Cuadrado-Corrales N, Sanchez-Valle R et al (2009) Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neuro 256:1620\u20138","journal-title":"Journal of Neurology"},{"issue":"3","key":"1251_CR28","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","volume":"53","author":"Maria Cramm","year":"2015","unstructured":"Cramm M, Schmitz M, Karch A, Mitrova E, Kuhn F, Schroeder B, Raeber A, Varges D et al (2016) Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol Neurobiol 53:1896\u20131904","journal-title":"Molecular Neurobiology"},{"issue":"8","key":"1251_CR29","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/jnnp.2003.020198","volume":"75","author":"E A Croes","year":"2004","unstructured":"Croes EA, Theuns J, Houwing-Duistermaat JJ, Dermaut B, Sleegers K, Roks G, van den Broeck M, van Harten B et al (2004) Octapeptide repeat insertions in the prion protein gene and early onset dementia. J Neurol Neurosurg Psychiatry 75:1166\u20131170","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"1251_CR30","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00415-002-0896-9","volume":"249","author":"GG Kov\u00e1cs","year":"2002","unstructured":"Kov\u00e1cs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RSG, Budka H (2002) Mutations of the prion protein gene: phenotypic spectrum. J Neurol 249:1567\u20131582","journal-title":"J Neurol"},{"issue":"6","key":"1251_CR31","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1007\/s12035-016-9918-y","volume":"54","author":"Matthias Schmitz","year":"2016","unstructured":"Schmitz M, Dittmar K, Llorens F, Gelpi E, Ferrer I, Schulz-Schaeffer WJ et al (2016) Hereditary human prion diseases: an update. Mol Neurobiol 54:4138\u20134149","journal-title":"Molecular Neurobiology"},{"issue":"7","key":"1251_CR32","doi-asserted-by":"publisher","first-page":"E1551","DOI":"10.1002\/humu.21281","volume":"31","author":"Jon A. Beck","year":"2010","unstructured":"Beck JA, Poulter M, Campbell TA, Adamson G, Uphill JB, Guerreiro R, Jackson GS, Stevens JC, Manji H, Collinge J, Mead S (2010) PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum Mutat 31(7):E1551\u201315563. \n                    https:\/\/doi.org\/10.1002\/humu.21281","journal-title":"Human Mutation"},{"issue":"3","key":"1251_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1750-3639.1998.tb00172.x","volume":"8","author":"Pasquale Montagna","year":"2006","unstructured":"Montagna P, Cortelli P, Avoni P, Tinuper P, Plazzi G, Gallassi R et al (1998) Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene. Brain Pathol [Internet] 8:515\u201320. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9669701","journal-title":"Brain Pathology"},{"key":"1251_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","volume":"66","author":"P Gambetti","year":"2003","unstructured":"Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66:213\u2013239","journal-title":"Br Med Bull"},{"issue":"7","key":"1251_CR35","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00415-006-0472-9","volume":"254","author":"P. Sanchez-Juan","year":"2007","unstructured":"Sanchez-Juan P, S\u00e1nchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrov\u00e1 E, Stoeck K, Sklaviadis T et al (2007) Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol 254:901\u2013906","journal-title":"Journal of Neurology"},{"issue":"3","key":"1251_CR36","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s12035-017-0479-5","volume":"55","author":"Franc Llorens","year":"2017","unstructured":"Llorens F, Kruse N, Karch A, Schmitz M, Zafar S, Gotzmann N, Sun T, K\u00f6chy S et al (2018) Validation of \u03b1-synuclein as a CSF biomarker for sporadic Creutzfeldt-Jakob disease. Mol Neurobiol Mol Neurobiol 55:2249\u20132257","journal-title":"Molecular Neurobiology"},{"key":"1251_CR37","unstructured":"Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY et al (2016) Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med 8:322ra9"},{"issue":"1","key":"1251_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ana.410380107","volume":"38","author":"Piero Parchi","year":"1995","unstructured":"Parchi P, Castellani R, Cortelli P, Montagna P, Chen SG, Petersen RB, Manetto V, Vnencak-Jones CL et al (1995) Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol 38:21\u201329","journal-title":"Annals of Neurology"},{"issue":"1-2","key":"1251_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000454802","volume":"43","author":"Franc Llorens","year":"2017","unstructured":"Llorens F, Karch A, Golanska E, Schmitz M, Lange P, Sikorska B et al (2017) Cerebrospinal fluid biomarker-based diagnosis of sporadic Creutzfeldt-Jakob disease: a validation study for previously established cutoffs. Dement Geriatr Cogn Disord 43:71\u201380","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"6","key":"1251_CR40","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jalz.2017.12.008","volume":"14","author":"Inga Zerr","year":"2018","unstructured":"Zerr I, Schmitz M, Karch A, Villar-Piqu\u00e9 A, Kanata E, Golanska E et al (2018) Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: evaluation of diagnostic accuracy in the differential diagnosis of prion diseases. Alzheimer\u2019s Dement 14:751\u2013763","journal-title":"Alzheimer's & Dementia"},{"key":"1251_CR41","doi-asserted-by":"crossref","unstructured":"Llorens F, Th\u00fcne K, Schmitz M, Ansoleaga B, Frau-M\u00e9ndez MA, Cramm M et al (2016) Identification of new molecular alterations in fatal familial insomnia. Hum Mol Genet 25:2417\u20132436","DOI":"10.1093\/hmg\/ddw108"},{"issue":"11","key":"1251_CR42","doi-asserted-by":"publisher","first-page":"8586","DOI":"10.1007\/s12035-018-1014-z","volume":"55","author":"Franc Llorens","year":"2018","unstructured":"Llorens F, Barrio T, Correia \u00c2, Villar-Piqu\u00e9 A, Th\u00fcne K, Lange P et al (2018) Cerebrospinal fluid prion disease biomarkers in pre-clinical and clinical naturally occurring scrapie. Mol Neurobiol. \n                    https:\/\/doi.org\/10.1007\/s12035-018-1014-z","journal-title":"Molecular Neurobiology"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1251-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T19:31:07Z","timestamp":1564428667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1251-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1251-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,30]]},"assertion":[{"value":"28 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The study was conducted according to the revised Declaration of Helsinki and Good Clinical Practice guidelines, and was approved by all local Ethics committees. All study participants or their legal guardians provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Dr. Lachmann reports he is a representative of AJ Roboscreen GmbH, Leipzig, Germany.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}